Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,392

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

ANTIOXIDANT AND ANTI-INFLAMMATORY PROPERTIES OF CURCUMIN

Menon, Venugopal P., Sudheer, Adluri Ram·2007·ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY
DOI 10.1007/978-0-387-46401-5_3
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/978-0-387-46401-5_3

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 103

  1. 1. A. Mukhopadhyay, N. Basu, N. Ghatak, and P. K. Gujral, Antiinflammatory and irritant activities of curcumin analogues in rats. Agents Actions 12, 508–515 (1982). · DOI · Paper page
  2. 2. A. C. Reddy and B. R. Lokesh, Effect of dietary turmeric (Curcuma longa) on iron induced lipid peroxidation in the rat liver. Food Chem Toxicol 32, 279–283 (1994). · DOI · Paper page
  3. 3. R. A. Sharma, A. J. Gescher, and W. P. Steward, Curcumin: The story so far. Eur J Cancer 41, 1955–1968 (2005). · DOI · Paper page
  4. 4. C. Kalpana, K. N. Rajasekharan, and V. P. Menon, Modulatory effects of curcumin and curcumin analog on circulatory lipid profiles during nicotine-induced toxicity in Wistar rats. J Med Food 8(2), 246–250 (2005). · DOI
  5. 5. A. R. Sudheer, C. Kapana, M. Srinivasan, and V P. Menon, Ferulic acid modulates altered lipid profiles and prooxidant/antioxidant status in circulation during nicotine-induced toxicity: A dose-dependent study. Toxicol Mech Methods 15, 1–7 (2005). · DOI
  6. 6. D. Harman, Aging: A theory based on free radical and radiation chemistry. J Gerentol 2, 298–300 (1956). · DOI · Paper page
  7. 7. A. P. Arrigo, Gene expression and thiol redox state. Free Radical Biol Med 27, 936–944 (1983). · DOI · Paper page
  8. 8. J. J. Hadad, Antioxidant and prooxidant mechanisms in the regulation of redox (Y)—sensitive factors. Cell Signal 14, 879–897 (1989). · DOI · Paper page
  9. 9. B. Halliwell and J. M. C. Gutteridge, Free Radicals in Biology and Medicine. Oxford University Press, Oxford, 1989, p. 63
  10. 12. B. Wood and A. Brooks, Human evolution: We are what we ate. Nature 400, 219–220 (1990). · DOI
  11. 13. J. S. Wright, Predicting the antioxidant activity of curcumin and curcuminoids. J Mol Struct (Theochem) 591, 207–217 (2002). · doi:10.1016/s0166-1280(02)00242-7
  12. 14. S. V. Jovanovic, S. Steenken, C. W. Boone, and M. G. Simic, H-atom transfer is a preferred antioxidant mechanism of curcumin. J Am Chem Soc 121, 9677–9681 (1999). · DOI · Paper page
  13. 15. L. R. C. Barclay, M. R. Vinqvist, K. Mukai, H. Goto, Y. Hashimoto, A. Tokuanga, and H. Uno, The antioxidant mechanism of curcumin: Classical methods are needed to determine antioxidant mechanism and activity. Org Lett 2, 2841–2843 (2000). · DOI · Paper page
  14. 16. K. I. Priyadarsini, D. K. Maity, G. H. Naik, M. S. Kumar, M. K. Unnikrishnan, J. G. Satav, and H. Mohan, Role of phenolic O:H and methylene hydrogen on the free radical reaction and antioxidant activity of curcumin. Free Radical. Biol Med 35, 475–484 (2003). · DOI · Paper page
  15. 17. Y. M. Sun, H. Y. Zhang, D. Z. Chen, and C. B. Liu, Theoretical elucidation on the antioxidant mechanism of curcumin: A DFT study. Org Lett 4, 2909–2911 (2002). · doi:10.1021/ol0262789
  16. 18. L. Shen, H. Y. Zhang, and H. F. Ji, Successful application of TD-DFT in transient absorption spectra assignment. Org Lett 7, 243–246 (2005). · DOI
  17. 19. G. Litwinienko and K. U. Ingold, Abnormal solvent effect on hydrogen atom abstraction: Resolution of the curcumin antioxidant controversy. The role of sequential proton loss electron transfer. J Org Chem 64, 5888–5896 (2004). · DOI · Paper page
  18. 20. M. T. Huang, T. Lysz, T. Ferraro, T. F. Abidi, J. D. Laskin, and A. H. Conney, Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 51, 813–819 (1991).
  19. 21. L. Qiao, V. Kozoni, G. J. Tsioulias, M. I. Koutsos, R. Hanif, and S. J. Shiff, Selected eicosaniods increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim Biophys Acta 1258, 215–223 (1995). · DOI · Paper page
  20. 22. C. D. Funk, L. B. Funk, M. E. Kennedy, A. S. Pong, and G. A. FitzGerald, Human platelet/erythroleukemia cell prostaglandin G/H synthase:cDNA cloning, expression and gene chromosomal assignment. FASEB J 5, 2304–2312 (1991). · DOI · Paper page
  21. 23. K. Subbaramaiah, N. Telang, J. T. Ramonetti, R. Araki, B. DeVito, B. B. Weksler, and A. J. Dannenberg, Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells Cancer Res 56, 4424–4429 (1996).
  22. 24. H. Y. Fang, T. S. Lin, J. P. Lin, Y. C. Wu, K. C. Chow, and L. S. Wang, Cyclooxygenase-2 in human non-small cell lung cancer. Eur J Surg Oncol 29, 171–177 (2003). · DOI
  23. 26. T. Kawamori, C. V. Rao, K. Seibert, and B. S. Reddy, Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58, 409–412 (1998).
  24. 27. F. Zhang, N. K. Altorki, J. R. Mestre, K. Subbaramaiah, and A. J. Dannenberg, Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis 20, 445–451 (1999). · DOI · Paper page
  25. 28. J. Hong, M. Bose, J. Ju, J. H. Ryu, X. Chen, and S. Sang, Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: Effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 25(9), 1671–1679 (2004). · DOI · Paper page
  26. 29. A. Goel, C. R. Boland, and D. P. Chauhan, Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett 172,111–118 (2001) · DOI · Paper page
  27. 30. Y. J. Surh, K. S. Chun, H. H. Cha, S. S. Han, Y. S. Keum, K. K. Park, and S. S. Lee, Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-kB activation. Mutat Res 480, 243–268 (2001). · DOI · Paper page
  28. 31. K. Chin, Y. Kurashima, T. Ogura, H. Tajiri, S. Yoshida, and Esumi, Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene 15, 437–442 (1997). · DOI · Paper page
  29. 32. N. V. Blough and O. C. Zafiriou, Reaction of superoxide with nitric oxide to form peroxynitrite in alkaline aqueous solution. Inorg Chem 24(4), 3502–3505 (1995).
  30. 33. C. Szabo and H. Ohshima, DNA damage induced by peroxynitrite: subsequent biological effects. Nitric Oxide 1, 373–385 (1997). · DOI · Paper page
  31. 34. Messmer U. K., M. Ankarcrona, P. Nicotera, and B. Brune, p53 expression in nitric oxide-induced apoptosis. FEBS Lett 355, 23–26 (1994). · DOI · Paper page
  32. 35. S. R. Goldstein, G. Y. Yang, X. Chen, S. K. Curtis, and C. S. Yang, Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma. Carcinogenesis 19, 1445–1449 (1998). · DOI
  33. 36. L. L. Thomsen, D. W. Miles, L. Happerfield, L. G. Bobrow, R. G. Knowles, and S. Moncada, Nitric oxide synthase activity in human breast cancer. Br J Cancer 72, 41–44 (1995). · DOI · Paper page
  34. 37. M. Takahashi, K. Fukuda, T. Ohata, and K. Wakabayashi, Increased expression of inducible and endothelial nitric oxide synthases in rat colon tumors induced by azoxymethane. Cancer Res 57, 1233–1237 (1997).
  35. 38. D. C. Jenkins, I. G. Charles, L. L. Thomsen, D. W. Moss, L. S. Holmes, S. A. Baylis, P. Rhodes, K. Westmore, P. C. Emson, and S. Moncada, Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92, 4392–4396 (1995). · DOI · Paper page
  36. 39. L. M. Landino, B. C. Crews, M. D. Timmons, J. D. Morrow, and L. J. Marnett, Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci USA 93, 15,069–15,074 (1996). · DOI · Paper page
  37. 40. I. Brouet and H. Ohshima, Curcumin, an anti-tumor promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 206, 533–540 (1995). · DOI · Paper page
  38. 41. M. M. Chan, H. I. Huang, M. R. Fenton, and D. Fong, In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol 55, 1955–1962 (1998). · DOI · Paper page
  39. 42. F. Chen, V. Castranova, X. Shi, and L. M. Demers, New insights into the role of nuclear factor-kB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 45, 7–17 (1999). · DOI · Paper page
  40. 43. D. Gius, A. Botero, S. Shah, and H. A. Curry, Oxidation/reduction status in the regulation of transcription factors NF-kB and AP-1. Toxicol Lett 106, 93–106 (1999). · DOI · Paper page
  41. 44. I. Luque and C. Gelinas, Rel/NF-kB and IkB factors in oncogenesis. Semin Cancer Biol 8, 103–111 (1997). · DOI
  42. 45. H. Jo, R. Zhang, T. A. McKinsey, J. Shao, R. D. Beauchap, D. W. Ballard, and P. Liang, NF-kB is required for H-ras oncogene-induced abnormal cell proliferation and tumorigenesis. Oncogene 19, 841–849 (2000). · DOI
  43. 46. S. Singh and B. B. Aggarwal, Activation of transcription factor NF-kB is suppressed by curcumin (diferuloylmethane). J Biol Chem 270, 24,995–25,000 (1995). · DOI · Paper page
  44. 47. F. H. Sarkar and Y. Li, Cell signaling pathways altered by natural chemopreventive agents. Mutat Res 555, 53–64 (2004). · DOI · Paper page
  45. 50. B. J. Sugarman, B. B. Aggarwal, P. E. Hass, I. S. Figari, M. A. Palladino, Jr., and H. M. Shepard, Recombinant human tumor necrosis factor-alpha: Effects on proliferation of normal and transformed cells in vitro. Science 230(4728), 943–945 (1985). · DOI · Paper page
  46. 51. S. Shishodia, H. M. Amin, R. Lai, and B. B. Aggarwal, Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 70(5), 700–713 (2005). · DOI · Paper page
  47. 52. P. A. Cerutti, Prooxidant states and tumor promotion. Science 227, 375–381 (1985). · DOI · Paper page
  48. 53. W. J. Kozumbo, M. A. Trush, and T. W. Kensler, Are free radicals invlolved in tumor promotion? Chem–Biol Interact 54, 199–207 (1985). · DOI
  49. 54. W. Troll and R. Wiesner, The role of oxygen free radicals as a possible mechanism of tumor promotion. Annu Rev Pharmacol Toxicol 25, 509–528 (1985). · DOI · Paper page
  50. 55. E. M. Perchellet and J. P. Perchellet, Characterization of the hydroperoxide response observed in mouse skin treated with tumor promoters in vivo. Cancer Res 49, 6193–6201 (1989).
  51. 56. J. J. Pence and J. J. Reiners, Murine epidermal xanthine oxidase activity: Correlation with degree of hyperplasia induced by tumor promoters. Cancer Res 47, 6388–6392 (1987).
  52. 57. L. Srinivas, T. Gindhart, and N. H. Colburn, Tumor-promoter resistant cells lack trisialoganglioside response. Proc Natl Acad Sci USA 79, 4988–4991 (1982). · doi:10.1073/pnas.79.16.4988
  53. 58. T. W. Kensler, D. M. Bush, and W. J. Kozumbo, Inhibition of tumor promotion by a biomimetic superoxide dismutase. Science 221, 75–77 (1983). · DOI · Paper page
  54. 59. L. J. Marnett, Peroxy free radicals: potential mediators of tumor initiation and promotion. Carcinogenesis 8, 1365–1373 (1987). · DOI · Paper page
  55. 60. A. K. Verma, C. L. Ashendel, and R K. Boutwell, Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 40, 308–315 (1980).
  56. 61. M. Nagabhushan and S. V. Bhide, Curcumin as an inhibitors of cancer. J Am Coll Nutr 11, 192–198 (1992). · DOI · Paper page
  57. 62. Y. P. Lu, R. L. Chang, M. T. Huang, and A. H. Conney, Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis. Carcinogenesis 14, 293–297 (1993). · DOI
  58. 63. Y. J. Surh, K. K. Park, K. S. Chun, J. M. Lee, E. Lee, and S. S. Lee, Anti-tumor promoting activities of selected pungent substances present in ginger. J Environ Toxicol Pathol Oncol 18, 131–139 (1999).
  59. 64. M. T. Huang, W. Ma, P. Yen, J. G. Xie, J. Han, K. Frenkel, D. Grunberger, and A. H. Conney, Inhibitory effects of topical application of low doses of curcumin on 12-O-tetra-decanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis. Carcinogenesis 18, 83–88 (1997). · DOI · Paper page
  60. 65. Y. Nakamura, Y. Ohto, A. Murakami, T. Osawa, and H. Ohigashi, Inhibitory effects of curcumin and tetrahydrocurcuminoids on the tumor promoter-induced reactive oxygen species generation in leukocytes in vitro and in vivo. Jpn J Cancer Res 89, 361–370 (1998). · DOI
  61. 66. T. S. Huang, S. C. Lee, and J. K. Lin, Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc Natl Acad. Sci USA 88, 5292–5296 (1991). · DOI · Paper page
  62. 67. S. Kilaru, S. G. Frangos, A. H. Chen, D. Gottler, A. Dhadwal, O. Araim, and B. E. Sumpio, Nicotine: A review of its role in atherosclerosis. J Am Coll Surg 193, 538–546 (2001). · DOI
  63. 68. R. Olszanecki, J. Jawien, M. Gajda, L. Mateuszuk, A. Gebska, M. Korabiowska, S. Chlopicki, and R. Korbut, Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. J Physiol Pharmacol 56(4), 627–635 (2005).
  64. 69. R. Srivastava, M. Dikshit, R. C. Srimal, and B. N. Dhawan, Anti-thrombotic effect of curcumin. Thromb Res 40(3), 413–417 (1985). · DOI
  65. 70. N. Toda, T. Okamura, I. Shimizu, and Y. Tatsuno, Postmortem functional changes in coronary and cerebral arteries from humans and monkeys. Cardiovasc Res 11, 707–713 (1985). · doi:10.1093/cvr/19.11.707
  66. 71. R. B. Arora, S. K. Gupta, R. C. Sharma, and H. H. Siddiqui, Isolation and characterization of a sodium retaining substance from pig heart muscle and its role in myocardial infarction. Indian J Med Res 59(3), 483–493 (1971).
  67. 72. S. Chandra, S. K. Mukherjee, and N. Sethi, Effect of argemone oil feeding on blood biochemistry and tissue changes in albino rats. Indian J Med Sci 26(5), 308–312 (1972).
  68. 73. R L. Saul, P. Gee, and B. N. Ames, Free radicals, DNA damage and aging. In: Modern Biological Theories of Aging, H. R. Warner (ed). Raven Press, New York, 1987.
  69. 74. D. Harman, Free radical theory of aging: Effect of free radical inhibitors on the mortality rate of male LAP mice, J Gerontol 23, 476–482 (1968). · DOI · Paper page
  70. 76. J. M. Talmashoff, T. Ouo, and R. G. Cutter, Superoxide dismutase: Correlation with life-span and specific metabolic rate in primate species. Proc Natl Acad Sci USA 77, 2777–2781 (1980). · DOI · Paper page
  71. 77. J. M. Ringman, S. A. Frautschy, G. M. Cole, D. L. Masterman, and J. L. Cummings, A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alzheimer Res 22(2), 131–136 (2005). · DOI · Paper page
  72. 78. M. Grundman, M. Grundman, and P. Delaney, Antioxidant strategies for Alzheimer's disease. Proc Nutr Soc. 61(2), 191–202 (2002). · DOI
  73. 79. R. C. Benyon and M. J. Arthur, Mechanisms of hepatic fibrosis. J. Pediatr Gastroenterol Nutr 27, 75–85 (1998). · doi:10.1097/00005176-199807000-00013
  74. 80. A. D. Burt, Cellular and molecular aspects of hepatic fibrosis. J Pathol 170, 105–114 (1993). · DOI
  75. 81. H. Nagase and F. Woessner, Jr., Matrix metallo proteinases. J Biol Chem 274, 21,491–21, 494 (1999). · DOI · Paper page
  76. 82. M. J. Arthur, Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 279(2), G245–G249 (2000). · DOI · Paper page
  77. 83. G. Akila, V. Rajakrishnan, P. Viswanathan, K. N. Rajashekaran, and V. P. Menon, Effects of curcumin on lipid profile and lipid peroxidation status in experimental hepatic fibrosis. Hepatol Res 11,147–157 (1998). · DOI
  78. 84. R. Rukkumani, K. Aruna, P. S. Varma, and V. P. Menon, Curcumin influences hepatic expression patterns of matrix metalloproteinases in liver toxicity. Italian J Biochem 53, 61–66 (2004).
  79. 85. B. Tesfamariam, Free radicals in diabetic endothelial cell dysfunction. Free Radical Biol Med 16, 383–391 (1994). · DOI · Paper page
  80. 86. A. Bierhaus, M. A. Hofmann, R. Ziegler, and P. Nawroth, AGE and other interaction with AGE-receptors in vascular disease and diabetes-I. The AGE concept. Cardiovasc Res 37, 586–590 (1998). · DOI · Paper page
  81. 87. G. L. King, H. Ishii, and D. Koya, Diabetic vascular dysfunction: A model of excessive activation of protein kinase C. Kidney Int 60, S77–S85 (1997).
  82. 88. J. R. Williamson, K. Chang, M. Frangos, K. S. Hasan, Y. Ido, T. Kawamura, J. R. Nyengaard, M. Van Den Enden, C. Kilo, and R. G. Tilton, Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42, 801–813 (1993). · DOI · Paper page
  83. 89. B. Goossens, J. Grooten, K. De Vos, and W. Fiers, Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci USA 92(18), 8115–8119 (1995). · DOI · Paper page
  84. 90. G. Boden, Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46(1), 3–10 (1997). · DOI · Paper page
  85. 91. C. R. Kahn, Causes of insulin resistance. Nature 373(6513), 384–385 (1995). · DOI
  86. 92. G. B. Sijitlal, P. Chitra, and G. Chandrakasan, Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. Biochem Pharmacol 56(12), 1067–1074 (1998).
  87. 93. T. Mahesh, M. Sri Balasubashini, and V. P. Menon, Photo irradiated curcumin supplementation in streptozotocin-induced diabetic rats: Effect on lipid peroxidation. Therapie 59(6), 639–644 (2004). · DOI
  88. 94. C. J. Li, L. J. Zhang, B. J. Dezube, C. S. Crumpacker, and A. B. Pardee, Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc Nat1 Acad Sci USA 90, 1839–1842 (1993). · DOI
  89. 95. A. Mazumder, K. Raghavan, J. Weinstein, K. W. Kohn, and Y. Pommier, Inhibition of human immunodeficiency virus type-l integrase by curcumin. Biochem Pharmacol. 49(8), 1165–1170 (1995). · DOI · Paper page
  90. 96. C. A. Janeway, The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 13, 11 (1992). · DOI · Paper page
  91. 97. C. Natarajan and J. J. Bright, Curcumin inhibits experimental allergicencephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T-cells and differentiation of neural antigen specific ThI cells. J Immunol 169, 6506 (2002). · DOI · Paper page
  92. 98. H. C. Huang, T. R. Jan, and S. F. Yeh, Inhibitory effect of curcumin, an anti-inflammatory agent, on vascular smooth muscle cell proliferation. Eur J Pharmacol 221, 381–385 (1992). · DOI
  93. 99. M. Kitagawa, H. Mitsui, H. Nakamura, S. Yoshino, S. Miyakawa, N. Ochiai, M. Onobori, H. Suzuki, and T. Sumida, Differential regulation of rheumatoid synovial cell interleukin-12 production by tumor necrosis factor alpha and CD 40 signals. Arthritis Rheum 42, 1917–1926 (1999). · doi:10.1002/1529-0131(199909)42:9<1917::aid-anr18>3.0.co;2-2
  94. 100. B. Bosman, Testing of lipoxygenase inhibitors, cycloxigenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis. Skin Pharmacol 7, 324–334 (1994). · doi:10.1159/000211314
  95. 101. M. C. Heng, M. K. Song, J. Harker, and M. K. Heng, Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. Br J Dermatol 143, 937–949 (2000). · doi:10.1046/j.1365-2133.2000.03767.x
  96. 102. A. Bernd, C. Theilig, S. Kippenberger, A. Ramirez-Bosca, M. Podda, J. Diaz, J. Miquel, and R. Kaufmann, An extract of Curcuma longa exerts anti-oxidative, anti-inflammatory and antiproliferative effects on human keratinocytes in vitro. J Invest Dermatol 109, 460–464 (1997).
  97. 103. A. Bernd, C. Theilig, S. Kippenberger, A. Ramirez-Bosca, J. Diaz, J. Miquel, and R. Kaufmann, Effect of Curcuma longa extract on the expression of proinflammatory cytokines. Skin Pharmacol App. Skin Physiol 13, 226–234 (2000).
  98. 104. I. Kurose, H. Higuchi, S. Kato, S. Miura, N. Watanabe, Y. Kamegaya, K. Tomita, M. Takaishi, Y. Haire, M. Fukuda, K. Mizukami, and H. Ishii, Oxidative stress on mitochondria and cell membrane of cultured rat hepatocytes and perfused liver exposed to ethanol. Gastroenterology 112, 1331–1343 (1997). · DOI
  99. 105. V. Rajakrishnan, P. Vishwanathan, K. N. Rajasekharan, G. Gunashekaran, and V. P. Menon, Role of curcumin in alcoholic hepatotoxicity. Med Sci Res 26, 715–719 (1998).
  100. 106. A. Helen, K. Krishnakumar, P. L. Vijayammal, and K. T. Augusti, Antioxidant effect of onion oil (Allium Cepa linn.) on the damages induced by nicotine in rats as compared to alpha-tocopherol. Toxicol Lett 116, 61–68 (2000). · DOI · Paper page
  101. 107. D. Yildiz, N. Ercal, and D. W. Armstrong, Nicotine enantiomers and oxidative stress. Toxicology 130, 155–165 (1998). · DOI
  102. 108. C. Kalpana and V. P. Menon, Modulatory effects of curcumin on lipid peroxidation and antioxidant status during nicotine-induced toxicity. Pol J Pharmacol 56, 581–586 (2004). · DOI
  103. 109. K. Polasa, A. N. Naidu, I. Ravindranath, and K. Krishnaswamy, Inhibition of B(a)P induced strand breaks in presence of curcumin Mutat. Res 557, 203–213 (2004). · DOI

Cited by

See all 1,392

Metadata

Authors
Menon, V. P., & Sudheer, A. R.
Venue
ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY
Publisher
Springer US
Published
2007-08-06
Volume
595
Pages
105-125
DOI
10.1007/978-0-387-46401-5_3
OpenAlex
W1258584912
Cited by
1,392
References
6
FWCI
10.32
Type
book chapter
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ANTIOXIDANT AND ANTI-INFLAMMATORY PROPERTIES OF CURCUMIN. https://app.cochat.ai/papers/10.1007/978-0-387-46401-5_3
The paper
Menon, V. P., & Sudheer, A. R. (2007). ANTIOXIDANT AND ANTI-INFLAMMATORY PROPERTIES OF CURCUMIN. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. https://doi.org/10.1007/978-0-387-46401-5_3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.